| Dr Marvin L Hage, MD | |
|
2131 S 17th St, Wilmington, NC 28401-7407 | |
| (910) 343-0161 | |
| (910) 772-9202 |
| Full Name | Dr Marvin L Hage |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 2131 S 17th St, Wilmington, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811992290 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 28202 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marvin L Hage, MD 2131 S 17th St, Wilmington, NC 28401-7407 Ph: (910) 343-0161 | Dr Marvin L Hage, MD 2131 S 17th St, Wilmington, NC 28401-7407 Ph: (910) 343-0161 |
News Archive
The U.S. Food and Drug Administration today announced that it is seeking expert scientific and clinical advice on the risks and benefits of metal-on-metal (MoM) hip systems as well as potential patient and practitioner recommendations on the use of MoM hip systems and the management of patients implanted with such devices. FDA will discuss these issues at a two-day expert advisory panel meeting on June 27-28, 2012.
BD (Becton, Dickinson and Company) today reported quarterly revenues of $1.898 billion for the fourth fiscal quarter ended September 30, 2009, representing an increase of 5 percent from the prior-year period, or 8 percent excluding the unfavorable impact from foreign currency translation.
Sanofi-aventis announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana (cabazitaxel) Injection, was published in the October 2, 2010 print edition of The Lancet in an article titled "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Oncotarget published "Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma" which reported that despite the rising incidence of human papillomavirus related oropharyngeal squamous cell carcinoma, treatment of metastatic disease remains palliative.
› Verified 9 days ago
John J Botti, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2212 Delaney Ave, Wilmington, NC 28403 Phone: 910-332-3660 Fax: 910-332-3668 | |
Dr. Donna R. Session, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Wilmington Fertility Center, 5815 Oleander Dr Suite 240, Wilmington, NC 28403 Phone: 910-444-1980 | |
Jennifer Calfee, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1809 Glen Meade Rd, Wilmington, NC 28403 Phone: 910-763-9833 Fax: 910-763-5166 | |
Andrea Foiles, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1809 Glen Meade Rd, Wilmington, NC 28403 Phone: 910-763-9833 | |
George Stewart, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1802 S 17th St, Wilmington, NC 28401 Phone: 910-343-1031 Fax: 910-341-1050 | |
Dr. Henry Alexander Easley Iii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-772-9202 Fax: 910-772-9452 | |
Vikki Brown, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1802 S 17th St, Wilmington, NC 28401 Phone: 910-343-1031 Fax: 910-341-1050 |